Literature DB >> 11445232

Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain.

M E Monzón1, M M Varas, S R De Barioglio.   

Abstract

In this study, the involvement of nitric oxide (NO) in the mechanism of anxiety was investigated. The rats received an intraamygdaline or intrahippocampal injection of the nitric oxide synthase inhibitor, N(G)-nitro-l-arginine (L-NOARG), and were then tested in the plus-maze test. L-NOARG induced a decrease in the time spent by rats in the open arms. Conversely, the administration of the melanin-concentrating hormone (MCH) into these structures increased the number of entries into the open arms as well as the time spent on them. MCH injected in rats pretreated with L-NOARG also was able to revert the anxiogenic effects of L-NOARG in amygdala.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445232     DOI: 10.1016/s0196-9781(01)00439-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats.

Authors:  Daniel Forestiero; Carlos Mora Manfrim; Francisco Silveira Guimarães; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

Review 2.  Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.

Authors:  Toshiharu Shimazaki; Takao Yoshimizu; Shigeyuki Chaki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  The regulation of alcohol intake by melanin-concentrating hormone in rats.

Authors:  Elizabeth A Duncan; Therese R Rider; Ronald J Jandacek; Deborah J Clegg; Stephen C Benoit; Patrick Tso; Stephen C Woods
Journal:  Pharmacol Biochem Behav       Date:  2006-12-22       Impact factor: 3.533

4.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

5.  Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function.

Authors:  Shuang Li; Yusuke Ohgami; Yang Dai; Raymond M Quock
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

6.  Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing.

Authors:  Joanna L Workman; Brian C Trainor; M Sima Finy; Randy J Nelson
Journal:  Behav Brain Res       Date:  2007-09-04       Impact factor: 3.332

7.  Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.

Authors:  P C M Spolidório; M B Echeverry; M Iyomasa; F S Guimarães; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-28       Impact factor: 4.530

8.  Changes in anxiety in abstinence correlate with the state of the nigrostriatal system in the rat hippocampus.

Authors:  D I Peregud; O N Vorontsova; A A Yakovlev; L F Panchenko; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2008-07-08

9.  The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK/MAP kinase.

Authors:  Kristie T Ota; Vicki J Pierre; Jonathan E Ploski; Kaila Queen; Glenn E Schafe
Journal:  Learn Mem       Date:  2008-10-02       Impact factor: 2.460

10.  Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.

Authors:  Anbrin Masood; Ying Huang; Hassan Hajjhussein; Lan Xiao; Hao Li; Wei Wang; Adel Hamza; Chang-Guo Zhan; James M O'Donnell
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.